APA
Nabholtz J. M., Abrial C., Mouret-Reynier M. A., Dauplat M. M., Weber B., Gligorov J., Forest A. M., Tredan O., Vanlemmens L., Petit T., Guiu S., Van Praagh I., Jouannaud C., Dubray-Longeras P., Tubiana-Mathieu N., Benmammar K. E., Kullab S., Bahadoor M. R. K., Radosevic-Robin N., Kwiatkowski F., Desrichard A., Cayre A., Uhrhammer N., Chalabi N., Chollet P. & Penault-Llorca F. (20151116). Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Nabholtz J M, Abrial C, Mouret-Reynier M A, Dauplat M M, Weber B, Gligorov J, Forest A M, Tredan O, Vanlemmens L, Petit T, Guiu S, Van Praagh I, Jouannaud C, Dubray-Longeras P, Tubiana-Mathieu N, Benmammar K E, Kullab S, Bahadoor M R K, Radosevic-Robin N, Kwiatkowski F, Desrichard A, Cayre A, Uhrhammer N, Chalabi N, Chollet P and Penault-Llorca F. 20151116. Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Nabholtz J. M., Abrial C., Mouret-Reynier M. A., Dauplat M. M., Weber B., Gligorov J., Forest A. M., Tredan O., Vanlemmens L., Petit T., Guiu S., Van Praagh I., Jouannaud C., Dubray-Longeras P., Tubiana-Mathieu N., Benmammar K. E., Kullab S., Bahadoor M. R. K., Radosevic-Robin N., Kwiatkowski F., Desrichard A., Cayre A., Uhrhammer N., Chalabi N., Chollet P. and Penault-Llorca F. (20151116). Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Nabholtz J M, Abrial C, Mouret-Reynier M A, Dauplat M M, Weber B, Gligorov J, Forest A M, Tredan O, Vanlemmens L, Petit T, Guiu S, Van Praagh I, Jouannaud C, Dubray-Longeras P, Tubiana-Mathieu N, Benmammar K E, Kullab S, Bahadoor M R K, Radosevic-Robin N, Kwiatkowski F, Desrichard A, Cayre A, Uhrhammer N, Chalabi N, Chollet P and Penault-Llorca F. Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. : Annals of oncology : official journal of the European Society for Medical Oncology. 20151116.